Check out your Company Bowl for anonymous work chats.
Annually, IV recognizes colleagues who made unique and exceptional contributions throughout the year with an Impact Award. Earlier this month, we celebrated five recipients who embody IV’s spirit of innovation and collaboration in a way that sets a positive example for others. Congratulations to our 2022 honorees – and thank you to everyone at IV for another incredible year!
The Fannie and John Hertz Foundation announced a new fellowship in honor of Nathan Myhrvold, IV Founder & CEO. As a result, five extraordinary Ph.D. students will receive the inaugural Nathan P. Myhrvold Fellowship in May 2023 to support their doctoral research. Thanks to an anonymous $5 million donation, “This new endowment doubles down on a winning bet on human ingenuity,” Nathan says. “In a world full of growing problems, that is one sure path to solutions.”
Congratulations to IV founder & CEO Nathan Myhrvold on his 900th US patent issued earlier this month. Nathan likes to say that “Invention is the closest thing to magic we have in the real world,” so here’s to making even more.
Congrats to the team at Ventrk, a healthcare company that spun out of IV’s Invention Science Fund! GeekWire interviewed Doug Baldwin Jr, Ventrk CEO, to learn more about the company and its two exercise-focused apps, TheraCentric and TrainCentric.
Congrats to the team at Ventrk, a healthcare company that spun out of IV’s Invention Science Fund! GeekWire interviewed Doug Baldwin Jr, Ventrk CEO, to learn more about the company and its two exercise-focused apps, TheraCentric and TrainCentric.
IV’s Deep Science Fund, led by Brian Holloway, published a report on its groundbreaking work to decrease the cost of drag — the resistance fluids such as air or water to move out of the way of a plane, ship or high-speed train — this week in Nature Communications.
Congrats to Somne, the latest company to launch out of our Invention Science Fund. With nearly 1 billion adults today suffering from obstructive sleep apnea (OSA), Somne is developing a revolutionary non-invasive alternative to CPAP machines and other treatments. Learn more at somne.co.
Congratulations to Mathen Ganesan on being named to IAM’s top 10 Market Makers for 2021! He'd be the first to acknowledge that this honor wouldn't be possible without the incredible team led by IIF COO Arvin Patel – congrats to the entire IIF team.
The New York Times calls Nathan Myhrvold, IV Founder and CEO, “One of the first people to realize the commercial potential of metamaterials…” Learn more about this exciting, emerging space that IV has been instrumental in for well over a decade.
Exciting coverage from IAM on the recent landmark deal. Congrats to Arvin Patel and the entire Invention Investment Fund team!
